ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,13862
-0,55%
Bitcoin
69.026,58
0,72%
Brent Oil
81,965
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. HCW Biologics Inc (HCWB)

  7. HCW Biologics Inc (HCWB) Notícias

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HCWB
DataHoraFonteTítuloCódigoCompanhia
20/05/202417:36Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:HCWBHCW Biologics Inc
15/05/202418:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
15/05/202417:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
15/05/202417:39GlobeNewswire Inc.HCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
15/05/202417:35Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HCWBHCW Biologics Inc
01/04/202417:10GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsNASDAQ:HCWBHCW Biologics Inc
27/02/202418:27Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
22/02/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
14/11/202309:00GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
08/11/202309:30GlobeNewswire Inc.Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNASDAQ:HCWBHCW Biologics Inc
01/11/202308:30GlobeNewswire Inc.Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual MeetingNASDAQ:HCWBHCW Biologics Inc
06/09/202308:30GlobeNewswire Inc.HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023NASDAQ:HCWBHCW Biologics Inc
11/08/202308:00GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
10/08/202318:01Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:HCWBHCW Biologics Inc
15/06/202318:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HCWBHCW Biologics Inc
14/06/202318:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HCWBHCW Biologics Inc
14/06/202308:30GlobeNewswire Inc.HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related DisordersNASDAQ:HCWBHCW Biologics Inc
09/05/202308:15GlobeNewswire Inc.HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
27/04/202317:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:HCWBHCW Biologics Inc
27/04/202317:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HCWBHCW Biologics Inc
27/04/202308:40GlobeNewswire Inc.HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development LoanNASDAQ:HCWBHCW Biologics Inc
13/04/202308:15GlobeNewswire Inc.HCW Biologics Poster Presentation at AACR Annual Meeting 2023NASDAQ:HCWBHCW Biologics Inc
03/04/202309:13GlobeNewswire Inc.A Novel Immunotherapeutic Approach to Treating Aging-Associated DiseasesNASDAQ:HCWBHCW Biologics Inc
28/03/202317:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HCWBHCW Biologics Inc
28/03/202317:25GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business HighlightsNASDAQ:HCWBHCW Biologics Inc
08/12/202209:55GlobeNewswire Inc.HCW Biologics Enters CRADA with National Cancer InstituteNASDAQ:HCWBHCW Biologics Inc
07/12/202209:30GlobeNewswire Inc.HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ PlatformNASDAQ:HCWBHCW Biologics Inc
14/11/202218:25TipRanksJonesTrading Keeps Their Buy Rating on HCW Biologics (HCWB)NASDAQ:HCWBHCW Biologics Inc
09/11/202215:15TipRanksMaxim Group Sticks to Its Buy Rating for HCW Biologics (HCWB)NASDAQ:HCWBHCW Biologics Inc
08/11/202209:00GlobeNewswire Inc.Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual MeetingNASDAQ:HCWBHCW Biologics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HCWB

Seu Histórico Recente

LSE
IDTK
Ishr Turkey
FX
USDINR
US Dollar vs INR
BIT
3LTS
Graniteshares 3x Long Te...
NASDAQ
AAYBEXX
Morgan Stanley Bank Na C...
BOV
EKTR4M
ELEKTRO PN
EU
EZSFG
Euronext VE Eurozone Soc...
USOTC
MKDTY
Molecular Data (CE)
EU
C252S
C252S
ASX
ISNR
BOV
EQIX34Q
Equinix
USOTC
GENSF
Genus (PK)
BIT
P92041
Bnp Paribas Issuance
LSE
SV61
Natixis 32
BTHB
SIXKRW
SIX Network
NYSE
PBR.A
Petroleo Brasileiro ADR
NASDAQ
BWOWU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados